Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts

doi:10.1083/jcb.123.4.1037

This Article

	Full Text (PDF, 2762K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Ekblom, M.
	Articles by Ekblom, P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Ekblom, M.
	Articles by Ekblom, P.


Social Bookmarking

	What's this?

ARTICLES

Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts

M Ekblom, R Fassler, B Tomasini-Johansson, K Nilsson and P Ekblom
Department of Pathology, Uppsala University, Sweden.

Tenascin, a predominantly mesenchymal extracellular matrix (ECM) glycoprotein has a rather restricted tissue distribution, but until now factors that inhibit its expression have not been identified. Glucocorticoids are known to be beneficial for establishment of myelopoiesis in long-term bone marrow cultures. Tenascin was found to be expressed in the bone marrow, and glucocorticoids were found to affect bone marrow tenascin expression. Both tenascin mRNAs and the mRNA of another ECM protein, laminin B1 chain, were drastically downregulated by glucocorticoids during initiation of bone marrow cultures. However, in already established long-term cultures glucocorticoids did not affect laminin B1 chain mRNA levels although tenascin mRNAs continued to be downregulated. Studies with a stromal cell line (MC3T3-G2/PA6) and fibroblasts (3T3) suggested that glucocorticoids act directly on the stromal cells that produce tenascin. In 3T3 cells this downregulation occurred within 12 h of glucocorticoid-treatment, suggesting that glucocorticoids acted through cis regulatory elements of the tenascin gene. We suggest that glucocorticoids in part regulate hematopoiesis by modifying the ECM. Furthermore, downregulation of tenascin expression by glucocorticoids may in part explain the restricted tissue distribution of tenascin in other tissues.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Jarvelainen, H., Sainio, A., Koulu, M., Wight, T. N., Penttinen, R. (2009). Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy. Pharmacol. Rev. 61: 198-223 [Abstract] [Full Text]
Stojadinovic, O., Lee, B., Vouthounis, C., Vukelic, S., Pastar, I., Blumenberg, M., Brem, H., Tomic-Canic, M. (2007). Novel Genomic Effects of Glucocorticoids in Epidermal Keratinocytes: INHIBITION OF APOPTOSIS, INTERFERON-{gamma} PATHWAY, AND WOUND HEALING ALONG WITH PROMOTION OF TERMINAL DIFFERENTIATION. J. Biol. Chem. 282: 4021-4034 [Abstract] [Full Text]
Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., Matsuzawa, Y. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96: 1723-1732 [Abstract] [Full Text]
Fluck, M, Tunc-Civelek, V, Chiquet, M (2000). Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J. Cell Sci. 113: 3583-3591 [Abstract]
Gu, Y., Sorokin, L., Durbeej, M., Hjalt, T., Jonsson, J.-I., Ekblom, M. (1999). Characterization of Bone Marrow Laminins and Identification of alpha 5-Containing Laminins as Adhesive Proteins for Multipotent Hematopoietic FDCP-Mix Cells. Blood 93: 2533-2542 [Abstract] [Full Text]
Talts, J., Wirl, G, Dictor, M, Muller, W., Fassler, R (1999). Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer. J. Cell Sci. 112: 1855-1864 [Abstract]
Ohta, M., Sakai, T., Saga, Y., Aizawa, S.-i., Saito, M. (1998). Suppression of Hematopoietic Activity in Tenascin-C-Deficient Mice. Blood 91: 4074-4083 [Abstract] [Full Text]
LAITINEN, A., ALTRAJA, A., KAMPE, M., LINDEN, M., VIRTANEN, I., LAITINEN, L.�A. (1997). Tenascin Is Increased in Airway Basement Membrane of Asthmatics and Decreased by an Inhaled Steroid. Am. J. Respir. Crit. Care Med. 156: 951-958 [Abstract] [Full Text]
Sakai, T, Furukawa, Y, Chiquet-Ehrismann, R, Nakamura, M, Kitagawa, S, Ikemura, T, Matsumoto, K (1996). Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J. Cell Sci. 109: 2069-2077 [Abstract]
Talts, J., Weller, A, Timpl, R, Ekblom, M, Ekblom, P (1995). Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma. J. Cell Sci. 108: 2153-2162 [Abstract]
Wirl, G, Hermann, M, Ekblom, P, Fassler, R (1995). Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J. Cell Sci. 108: 2445-2456 [Abstract]
Chammas, R, Taverna, D, Cella, N, Santos, C, Hynes, N. (1994). Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. J. Cell Sci. 107: 1031-1040 [Abstract]